Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration

NCT: NCT07725055 · NOT_YET_RECRUITING

NCT IDNCT07725055
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2030-04
SponsorCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts (OTHER)
First posted
Last updated

Brief Summary

Primary objective: \- Acquisition and analysis of images for non-medical purposes using the MONA IV system, an adaptive-optics-corrected scanning ophthalmoscope. Secondary objectives: * To measure the reproducibility of assessments; * To evaluate the detection of progressive changes.

Frequently Asked Questions

What is AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration?

AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration is a clinical trial registered under NCT07725055. Current status: NOT_YET_RECRUITING.

What is the status of NCT07725055?

The current status of NCT07725055 (AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration) is: NOT_YET_RECRUITING.

When did AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration start?

AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration started on 2026-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑